Alvotech Reports Mixed Fortunes: Revenue Rises, But Stock Dips Amid FDA Concerns
Alvotech, Iceland’s largest pharmaceutical company by revenue, is currently navigating a challenging period. The company specialises in developi...
Alvotech, Iceland’s largest pharmaceutical company by revenue, is currently navigating a challenging period. The company specialises in developi...
Denmark is one of Europe’s most competitive nations when it comes to the availability and cost of generic drugs. A recent study by the European Commis...
The legal drugs market has finally been cracked open now that Sweden’s state-run monopoly on pharmacies has officially ended. This will allow new comp...
Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office i...
Figures just released from Denmark’s National Patient Registry indicate a substantial rise in the number of teenage girls who have been admitted to ho...
Clamelle Chlamydia Test Kits will soon be available in UK pharmacies allowing customers to test for Chlamydia without the need to visit a doctor or ho...
Employees from many of Actavis Group‘s diverse departments worldwide will be present at this year’s annual CPhI conference, which is held ...
Actavis, a generic pharmaceutical manufacturer based in Iceland, has launched a generic drug for prostate cancer in the United Kingdom. The drug Bical...